Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 7
2020 7
2021 5
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Click Chemistry and Radiochemistry: An Update.
Bauer D, Cornejo MA, Hoang TT, Lewis JS, Zeglis BM. Bauer D, et al. Bioconjug Chem. 2023 Nov 15;34(11):1925-1950. doi: 10.1021/acs.bioconjchem.3c00286. Epub 2023 Sep 22. Bioconjug Chem. 2023. PMID: 37737084 Free PMC article. Review.
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET.
Keinänen O, Sarrett SM, Delaney S, Rodriguez C, Dayts EJ, Capone E, Sauniere F, Ippoliti R, Sala G, Iacobelli S, Zeglis BM. Keinänen O, et al. Mol Pharm. 2023 Jun 5;20(6):3241-3248. doi: 10.1021/acs.molpharmaceut.3c00241. Epub 2023 May 16. Mol Pharm. 2023. PMID: 37191353 Free PMC article.
Dual Radionuclide Theranostic Pretargeting.
Keinänen O, Brennan JM, Membreno R, Fung K, Gangangari K, Dayts EJ, Williams CJ, Zeglis BM. Keinänen O, et al. Mol Pharm. 2019 Oct 7;16(10):4416-4421. doi: 10.1021/acs.molpharmaceut.9b00746. Epub 2019 Sep 9. Mol Pharm. 2019. PMID: 31483993 Free PMC article.
Click Here for Better Chemistry.
Zeglis BM, Lewis JS. Zeglis BM, et al. N Engl J Med. 2022 Dec 15;387(24):2291-2293. doi: 10.1056/NEJMcibr2213596. Epub 2022 Nov 30. N Engl J Med. 2022. PMID: 36449446 Free PMC article. No abstract available.
89Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe.
Fung K, Vivier D, Keinänen O, Sarbisheh EK, Price EW, Zeglis BM. Fung K, et al. Molecules. 2020 May 15;25(10):2315. doi: 10.3390/molecules25102315. Molecules. 2020. PMID: 32429033 Free PMC article.
The Impact of FcγRI Binding on Immuno-PET.
Vivier D, Sharma SK, Adumeau P, Rodriguez C, Fung K, Zeglis BM. Vivier D, et al. J Nucl Med. 2019 Aug;60(8):1174-1182. doi: 10.2967/jnumed.118.223636. Epub 2019 Feb 7. J Nucl Med. 2019. PMID: 30733320 Free PMC article.
Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA, Delaney S, Cook BE, Genady AR, Hoerres R, Kuchuk M, Makris G, Valliant JF, Sadeghi S, Lewis JS, Hennkens HM, Bryan JN, Zeglis BM. Maitz CA, et al. Mol Pharm. 2022 Sep 5;19(9):3153-3162. doi: 10.1021/acs.molpharmaceut.2c00220. Epub 2022 May 30. Mol Pharm. 2022. PMID: 35635337 Free PMC article.
Cadherin-17 as a target for the immunoPET of adenocarcinoma.
Delaney S, Keinänen O, Lam D, Wolfe AL, Hamakubo T, Zeglis BM. Delaney S, et al. Eur J Nucl Med Mol Imaging. 2024 Apr 16. doi: 10.1007/s00259-024-06709-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38625402
36 results